Skip to main content
. 2023 Feb 24;12(2):619–633. doi: 10.1007/s40120-022-00431-y

Fig. 4.

Fig. 4

Association between core clinical characteristics at disease onset and treatment initiation with an oral corticosteroid/IST or a monoclonal antibody in newly diagnosed patients who received therapy at any point (N = 400). IST, immunosuppressive therapy. *p < 0.05 (corrected p value via SPSS). The z-test was used for pairwise comparisons of proportions, and the Bonferroni correction was applied to this test